We demonstrate that adipose ANGPTL4 governs plasma TAG levels by modulating LPL activity, and as a consequence, impacts associated metabolic outcomes including progression of atherosclerosis and glucose homeostasis in mice. This evidence concerns the gene ANGPTL4 and atherosclerosis.